Cargando…

Image-Guided Proton Therapy for Elderly Patients with Hepatocellular Carcinoma: High Local Control and Quality of Life Preservation

SIMPLE SUMMARY: The number of very elderly patients with hepatocellular carcinoma (HCC) aged 80 years and older has been steadily increasing with extensions in life expectancy due to improvements in medication and healthcare, and many recent studies focused on this specific population. Since these p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwata, Hiromitsu, Ogino, Hiroyuki, Hattori, Yukiko, Nakajima, Koichiro, Nomura, Kento, Hayashi, Kensuke, Toshito, Toshiyuki, Sasaki, Shigeru, Hashimoto, Shingo, Mizoe, Jun-etsu, Shibamoto, Yuta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827493/ https://www.ncbi.nlm.nih.gov/pubmed/33435340 http://dx.doi.org/10.3390/cancers13020219

Ejemplares similares

Changes in sexual function and serum testosterone levels in patients with prostate cancer after image-guided proton therapy
por: Hattori, Yukiko, et al.
Publicado: (2021)

Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia
por: Hashimoto, Shingo, et al.
Publicado: (2022)

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer
por: Nakajima, Koichiro, et al.
Publicado: (2018)

Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity
por: Iwata, Hiromitsu, et al.
Publicado: (2019)

Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer
por: Nakajima, Koichiro, et al.
Publicado: (2022)

Spot Scanning Proton Therapy for Sinonasal Malignant Tumors
por: Nakajima, Koichiro, et al.
Publicado: (2021)

Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study
por: Hashimoto, Shingo, et al.
Publicado: (2016)

Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death and cell cycle distribution
por: Iwata, Hiromitsu, et al.
Publicado: (2020)

Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses
por: Iwata, Hiromitsu, et al.
Publicado: (2013)

Comparison of multileaf collimator and conventional circular collimator systems in Cyberknife stereotactic radiotherapy
por: Murai, Taro, et al.
Publicado: (2017)

Efficacy of the Dynamic Jaw Mode in Helical Tomotherapy With Static Ports for Breast Cancer
por: Sugie, Chikao, et al.
Publicado: (2015)

Impact on dose distribution and volume changes of a bioabsorbable polyglycolic acid spacer during chemo-proton therapy for a pediatric Ewing sarcoma
por: Kimura, Mitsuhiro, et al.
Publicado: (2020)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Long‐term outcomes of proton therapy for prostate cancer in Japan: a multi‐institutional survey of the Japanese Radiation Oncology Study Group
por: Iwata, Hiromitsu, et al.
Publicado: (2018)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
por: Ogawa, Yasutaka, et al.
Publicado: (2018)

Dosimetric verification of IMPT using a commercial heterogeneous phantom
por: Yasui, Keisuke, et al.
Publicado: (2019)

A quality assurance for respiratory gated proton irradiation with range modulation wheel
por: Yasui, Keisuke, et al.
Publicado: (2018)

Long-term multidisciplinary treatment including proton therapy for a recurrent low-grade endometrial stromal sarcoma and pathologically prominent epithelial differentiation: an autopsy case report
por: Maeda, Osamu, et al.
Publicado: (2020)

Evaluation of dosimetric advantages of using patient‐specific aperture system with intensity‐modulated proton therapy for the shallow depth tumor
por: Yasui, Keisuke, et al.
Publicado: (2017)

Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2013)

Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2016)

Applicability of the linear–quadratic model to single and fractionated radiotherapy schedules: an experimental study
por: Miyakawa, Akifumi, et al.
Publicado: (2014)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas
por: MANABE, Yoshihiko, et al.
Publicado: (2017)

Comparison of intensity-modulated radiotherapy with the 5-field technique, helical tomotherapy and volumetric modulated arc therapy for localized prostate cancer
por: Kita, Nozomi, et al.
Publicado: (2022)

Dose–volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays
por: Hayashi, Akihiro, et al.
Publicado: (2015)

Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
por: Baba, Fumiya, et al.
Publicado: (2010)

Evaluation of radiophotoluminescent glass dosimeter response for therapeutic spot scanning proton beam: suggestion of linear energy transfer‐based correction
por: Nagata, Junya, et al.
Publicado: (2021)

Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma
por: Tsai, Yu-Lun, et al.
Publicado: (2020)

Changes in the Proliferation Rate, Clonogenicity, and Radiosensitivity of Cultured Cells During and After Continuous Low-Dose-Rate Irradiation
por: Wang, Zhen, et al.
Publicado: (2019)

Immune-maximizing (IMAX) therapy for cancer: Combination of dendritic cell vaccine and intensity-modulated radiation
por: SHIBAMOTO, YUTA, et al.
Publicado: (2013)

Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2019)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Optimal timing of a γH2AX analysis to predict cellular lethal damage in cultured tumor cell lines after exposure to diagnostic and therapeutic radiation doses
por: Takano, Seiya, et al.
Publicado: (2023)

Hemoptysis due to Pulmonary Arteriovenous Malformation after Coil Embolization during Long-Term Follow-Up
por: Shimohira, Masashi, et al.
Publicado: (2019)

Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning
por: Tsubouchi, Toshiro, et al.
Publicado: (2021)

Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience
por: Iwabuchi, Michio, et al.
Publicado: (2016)

Fertility preservation and pregnancy outcomes in adolescent and young adult male patients with cancer
por: Ukita, Yuji, et al.
Publicado: (2018)

Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly‐developed tumor‐tracking system and cyberknife
por: Manabe, Yoshihiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o6v74job8sh3qrn1kpto2srb91